The inhibitory effect of the cerebellar fastigial stimulation on ADH secretion

The Journal of Physiology
|November 1, 1974
PubMed

Insights

The cerebellum

Area of Science:

  • Neuroscience
  • Cardiovascular Physiology
  • Endocrinology

Background:

  • The cerebellum's role in autonomic and hormonal regulation is not fully understood.
  • Investigating cerebellar influence on cardiovascular and antidiuretic hormone (ADH) responses is crucial.

Purpose of the Study:

  • To examine the cardiovascular and ADH responses to neural inputs in cats.
  • To determine the effect of cerebellar fastigial nucleus stimulation on these responses.

Main Methods:

  • Experiments were conducted on paralyzed, anesthetized cats.
  • Carotid occlusion and electrical stimulation of the cerebellar fastigial nucleus were employed.
  • Cardiovascular parameters and ADH secretion were monitored.

Main Results:

  • Carotid occlusion increased cardiovascular responses and ADH secretion.
  • Simultaneous fastigial nucleus stimulation during carotid occlusion facilitated cardiovascular responses but inhibited ADH secretion.
  • Fastigial nucleus stimulation alone caused hypertension and tachycardia (fastigial pressor response) without consistent ADH changes.

Conclusions:

  • Cerebellar modulation of ADH secretion likely occurs via the lower brain stem, not directly through the hypothalamo-hypophysial system.
  • The fastigial pressor area is involved in regulating cardiovascular, autonomic, and pituitary hormonal responses.

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Direct-Acting Cholinergic Agonists: Pharmacological Actions00:59

Direct-Acting Cholinergic Agonists: Pharmacological Actions

Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.